New drug combo offers hope for tough blood cancers
NCT ID NCT06419634
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests a new drug, BMS-986497, in people with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) that has returned or not improved after prior treatments. The drug is given alone or combined with standard medicines (azacitidine and venetoclax). The main goals are to check safety, find the best dose, and see if the drug helps control the cancer. About 105 adults will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Columbia University Irving Medical Center
WITHDRAWNNew York, New York, 10032, United States
-
Hospital Clínic de Barcelona
RECRUITINGBarcelona, Catalunya [Cataluña], 08036, Spain
Contact Phone: •••-•••-••••
-
Hospital Universitario Virgen Del Rocio
RECRUITINGSeville, 41013, Spain
Contact Phone: •••-•••-••••
-
Jewish General Hospital
RECRUITINGMontreal, Quebec, H3T 1E2, Canada
Contact Phone: •••-•••-••••
-
John Theurer Cancer Center at Hackensack University Medical Center
RECRUITINGHackensack, New Jersey, 07601, United States
Contact Phone: •••-•••-••••
-
Local Institution - 0007
WITHDRAWNBoston, Massachusetts, 02114, United States
-
Local Institution - 0009
WITHDRAWNFairfax, Virginia, 22031, United States
-
Local Institution - 0017
NOT_YET_RECRUITINGMarseille, Bouches-du-Rhône, 13273, France
Contact
-
Local Institution - 0018
NOT_YET_RECRUITINGParis, 75010, France
Contact
-
Local Institution - 0022
NOT_YET_RECRUITINGToulouse, 31100, France
Contact
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Phone: •••-•••-••••
-
Northwestern Memorial Hospital
RECRUITINGChicago, Illinois, 60611, United States
Contact Phone: •••-•••-••••
-
Princess Margaret Cancer Centre
RECRUITINGToronto, Ontario, M5G 2M9, Canada
Contact Phone: •••-•••-••••
-
University of Texas MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-••••
-
Washington University School of Medicine, Siteman Cancer Center
RECRUITINGSt Louis, Missouri, 63108, United States
Contact Phone: •••-•••-••••
-
Yale-New Haven Hospital
RECRUITINGNew Haven, Connecticut, 06510, United States
Contact Phone: •••-•••-••••